Firm
The introduction of Canada’s patent term adjustment has left practitioners sceptical about its value, with high fees and limited eligibility meaning SMEs could lose out
With the US privacy landscape more fragmented and active than ever and federal legislation stalled, lawyers at Sheppard Mullin explain how states are taking bold steps to define their own regimes
A vote to be held in 2026 could create Hogan Lovells Cadwalader, a $3.6bn giant with 3,100 lawyers across the Americas, EMEA and Asia Pacific
Varuni Paranavitane of Finnegan and IP counsel Lisa Ribes compare and contrast two recent AI copyright decisions from Germany and the UK
Recently published Special Focus articles
Recently published Special Focus articles
-
Sponsored by Patrinos & KilimirisEvangelia Sioumala of Patrinos & Kilimiris looks at a recent judgment from the Athens Administrative Court of First Instance that favours the verbal elements of a trademark -
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law looks at how the Korean Intellectual Property Office (KIPO) and the Korean courts have judged the registrability and validity of pharmaceutical trademarks according to more specific criteria
-
Sponsored by Gün and PartnersUğur Aktekin and Zeynep Seda Alhas of Gün and Partners explore how the disruption caused by the coronavirus pandemic affected the enforcement of trademark rights in Turkey
-
Sponsored by AJ ParkAJ Park discusses the impact of the RCEP agreement on geographical indications and Māori traditional knowledge in New Zealand
-
Sponsored by GoldenGate LawyersBruce Fu of GoldenGate Lawyers explains the key changes that will streamline the registration procedure and better protect the interests of enterprises
-
Sponsored by Daniel LawRafael Salomão Romano and Samantha Salim of Daniel Law outline how the instructions will improve transparency and accountability in the Brazilian pharmaceutical patent scene
